No photo of David A Morilak

View Scopus Profile

David A Morilak

  • 5690 Citations
  • 45 h-Index
1983 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David A Morilak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

CENTRAL ANF AND CARDIOVASCULAR REGULATION

Morilak, D. A.

National Institutes of Health

6/15/87 → …

Project: Research project

Cognitive impairment associated with androgen deprivation therapy for prostate cancer

Morilak, D. A.

Project: Research project

Treating PTSD and depression: Mechanisms of pharmacotherapy and psychotherapy in rats

Morilak, D. A. & Frazer, A.

Project: Research project

Integrated Graduate Training Program in Neuroscience, UTHSCSA

Morilak, D. A.

National Institutes of Health

7/1/13 → 6/30/18

Project: Research project

    • South Texas Advanced Research Training: Undergraduate Program (START-UP)

    Frazer, A., Weiss, D. S. & Morilak, D. A.

    National Institutes of Health

    9/30/10 → 8/31/16

    Project: Research project

    • Research Output

    A rodent model of exposure therapy: The use of fear extinction as a therapeutic intervention for PTSD

    Paredes, D. & Morilak, D. A., Jan 30 2019, In : Frontiers in Behavioral Neuroscience. 13, 46.

    Research output: Contribution to journal › Review article

    Open Access
    • 4 Scopus citations

    Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning

    Girotti, M., Silva, J. D., George, C. M. & Morilak, D. A., Dec 1 2019, In : Neuropharmacology. 160, 107791.

    Research output: Contribution to journal › Article

    • Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer

    Sharp, A. M., Lertphinyowong, S., Yee, S. S., Paredes, D., Gelfond, J., Johnson-Pais, T. L., Leach, R. J., Liss, M., Risinger, A. L., Sullivan, A. C., Thompson, I. M. & Morilak, D. A., Nov 1 2019, In : Psychopharmacology. 236, 11, p. 3183-3195 13 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Activity in the ventral medial prefrontal cortex is necessary for the therapeutic effects of extinction in rats

    Fucich, E. A., Paredes, D., Saunders, M. O. & Morilak, D. A., Feb 7 2018, In : Journal of Neuroscience. 38, 6, p. 1408-1417 10 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations

    Ketamine corrects a deficit in reversal learning caused by chronic intermittent cold stress in female rats

    Paredes, D., Silva, J. D. & Morilak, D. A., Jan 1 2018, In : International Journal of Neuropsychopharmacology. 21, 12, p. 1109-1113 5 p.

    Research output: Contribution to journal › Article

    Open Access

    • Press / Media

    University of Texas Health Science Center at San Antonio: Free Public Symposium Nov. 30 to Break Down Schizophrenia's Walls

    David A Morilak, Daniel J Lodge & Dawn I Velligan

    11/16/18

    1 item of Media coverage

    Press/Media: Press / Media

    CPRIT Awards UT Health San Antonio Researcher Nearly $900,000 to Study Cognitive Impairment

    David A Morilak

    2/22/18

    1 item of Media coverage

    Press/Media: Press / Media